-
Mashup Score: 0
The FDA announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately.
Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Optimisticc | Study on Microbiome & Colorectal Cancer - 5 year(s) ago
E. coli & its relationship to colon cancer May 14, 2020 Cayetano Pleguezuelos Manzano, Jens Puschhof, and Axel Rosendahl Huber (Hubrecht Institute and Princess Maxima Center)… Does the microbiome promote human cancer? Mar 24, 2020 Dr. Matthew Meyerson (Dana-Farber Cancer Institute) presents his group’s work on the cancer microbiome for the… Dr. Kimmie Ng interviewed on…
Source: www.optimisticc.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
From one of our investigators for #OPTIMISTICC @CRUKresearch https://t.co/zGbYVvB9QQ https://t.co/P1nIM0V5hL
-
Discover #OPTIMISTICC Opportunity To Investigate Microbiome’s Impact on Science & Treatment In Colorectal Cancer comprised of an international team of scientists/physicians & advocates https://t.co/zGbYVvB9QQ #microbiome #crc #colorectalcancer #cancergrandchallenges @CRUKresearch
-
-
Mashup Score: 0Optimisticc | Study on Microbiome & Colorectal Cancer - 5 year(s) ago
E. coli & its relationship to colon cancer May 14, 2020 Cayetano Pleguezuelos Manzano, Jens Puschhof, and Axel Rosendahl Huber (Hubrecht Institute and Princess Maxima Center)… Does the microbiome promote human cancer? Mar 24, 2020 Dr. Matthew Meyerson (Dana-Farber Cancer Institute) presents his group’s work on the cancer microbiome for the… Dr. Kimmie Ng interviewed on…
Source: www.optimisticc.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
Discover #OPTIMISTICC Opportunity To Investigate Microbiome’s Impact on Science & Treatment In Colorectal Cancer comprised of an international team of scientists/physicians & advocates https://t.co/rc3o2xVYmJ #microbiome #crcsm #crc #colorectalcancer #cancergrandchallenges @CR_UK
-
-
Mashup Score: 1Optimisticc | Study on Microbiome & Colorectal Cancer - 5 year(s) ago
E. coli & its relationship to colon cancer May 14, 2020 Cayetano Pleguezuelos Manzano, Jens Puschhof, and Axel Rosendahl Huber (Hubrecht Institute and Princess Maxima Center)… Does the microbiome promote human cancer? Mar 24, 2020 Dr. Matthew Meyerson (Dana-Farber Cancer Institute) presents his group’s work on the cancer microbiome for the… Dr. Kimmie Ng interviewed on…
Source: www.optimisticc.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
Discover our project #OPTIMISTICC the Opportunity To Investigate the Microbiome’s Impact on Science and Treatment In Colorectal Cancer comprised of an international team of scientists/physicians & advocates https://t.co/rc3o2xVYmJ #microbiome #crcsm #crc #colorectalcancer #cruk
-
-
Mashup Score: 4
AMG 510, a novel KRAS G12C inhibitor, demonstrated early evidence of a consistent safety profile and anticancer activity across a range of advanced KRAS G12C-mutant solid tumors other than non–small cell lung cancer and colorectal cancer.
Source: OncLiveCategories: Hem/Oncs, Latest HeadlinesTweet-
AMG 510 Shows Clinical Activity in Advanced KRAS G12C-Mutant Solid Tumors https://t.co/jYzE7jxDrY via @onclive @ccalliance #asco2020
-
-
Mashup Score: 3Meeting Library | Meeting Library - 5 year(s) ago
2318 Mill Road, Suite 800, Alexandria, VA 22314 · 571-483-1300 ©2020 American Society of Clinical Oncology (ASCO). All Rights Reserved Worldwide.
Source: meetinglibrary.asco.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
#asco2020 @ccalliance KRAS mutations most prominent oncogenic driver mutations in human cancer. No agents targeting KRAS have been approved. Demonstrated clinical activity in pts with advanced KRAS p.G12C mutant solid tumors other than NSCLC and CRC https://t.co/ntYOZiBFQW
-
-
Mashup Score: 0
The FDA has issued a guidance regarding clinical trials during the Coronavirus disease 2019 pandemic in recognition of the challenges that may impact standard clinical trial procedures. The guidance acts as a set of recommendations to maintain the safety of patients enrolled onto trials and the trial’s integrity.
Source: Targeted OncologyCategories: Hem/OncsTweet-
FDA Issues Guidance on Conducting Clinical Trials During COVID-19 Pandemic https://t.co/ZKN3UNGae7 via @TargetedOnc
-
-
Mashup Score: 0Colorectal cancer statistics, 2020 - 5 year(s) ago
Colorectal cancer (CRC) is the second most common cause of cancer death in the United States. Every 3 years, the American Cancer Society provides an update of CRC occurrence based on incidence data (…
Source: American Cancer Society JournalsCategories: Hem/OncsTweet-
"In 2020, ~147,950 will be diagnosed with CRC and 53,200 will die, 17,930 cases and 3,640 deaths in < 50 years. CRC death 2008-2017 decreased 3% annually in >65 years, 0.6% annually in 50-64 years while increasing by 1.3% annually in <50 years." #crcsm https://t.co/PYRfqmwDbV
-
-
Mashup Score: 0Tracing the toxic fingerprint of a bacterium in our gut - 5 year(s) ago
Our Grand Challenge scientists have discovered that a common type of bacteria found in our guts could contribute to bowel cancer.
Categories: Hem/OncsTweet-
Tracing the toxic fingerprint of a bacterium in our gut https://t.co/xEWLAxNNJM great work from our team OPTIMISTICC a @CR_UK Grand Challenge Team
-
-
Mashup Score: 0Never too late to quit: protective cells could cut risk of lung cancer for ex-smokers - 5 year(s) ago
Protective cells in the lungs of ex-smokers could explain why quitting smoking reduces the risk of developing lung cancer.
Source: Cancer Research UKCategories: Hem/OncsTweet-
In London for CRUK Grand Challenge Summit for our microbiome team. Good news "it is never too late to quit smoking" https://t.co/G1aPHbEyjf
-
All Ranitidine Products (Zantac): Press Release - FDA Requests Removal https://t.co/SDhBAtWesB including liquid products